Dr. Modjarrad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health
40 Convent Drive, Room 2508 MSC3017
Bethesda, MD 20892Phone+1 301-594-8555
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2012 - 2013
- Vanderbilt University Medical CenterFellowship, Infectious Disease, 2010 - 2012
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2008 - 2010
- Yale-New Haven Medical CenterInternship, Internal Medicine, 2006 - 2007
- University of Alabama School of MedicineClass of 2006
Certifications & Licensure
- MD State Medical License 2016 - 2025
- WV State Medical License 2012 - 2025
- VA State Medical License 2012 - 2016
- TN State Medical License 2010 - 2014
Publications & Presentations
PubMed
- 3 citationsLassa virus in novel hosts: insights into the epidemiology of lassa virus infections in southern Nigeria.Anise Nkenjop Happi, Olusola Akinola Ogunsanya, Akeemat Opeyemi Ayinla, Ayotunde Elijah Sijuwola, Femi Mudasiru Saibu
Emerging Microbes & Infections. 2024-12-01 - 2 citationsSafety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, acti...Kayvon Modjarrad, Paul T Scott, Melanie McCauley, Brittany Ober-Shepherd, Erica Sondergaard
The Lancet. Infectious Diseases. 2024-12-01 - SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity.Elizabeth J Martinez, William C Chang, Wei-Hung Chen, Agnes Hajduczki, Paul V Thomas
Iscience. 2024-10-18
Press Mentions
- Development of Universal COVID Vaccine Emerges as New Challenge for Pharmaceutical IndustryApril 23rd, 2022
- Pan-Coronavirus Vaccines May Be Key to Fighting Future PandemicsMarch 8th, 2022
- U.S. Army Begins Human Trials of Pan-Coronavirus VaccineJanuary 31st, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: